1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Aridis Pharmaceuticals, Inc.

Aridis Pharmaceuticals, Inc.

ARDS
Aridis Pharmaceuticals, Inc.US flagOther OTC
0.00
USD
- -
- -
8,915.00Market Cap

Income Statement (USD)

APIChat
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
Sales/Revenue/Turnover
2
1
3
- -
- -
- -
- -
+ Sales & Services Revenue
2
1
3
- -
- -
- -
- -
- Cost of Revenue
2
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
2
- -
- -
- -
- -
- -
- -
Gross Profit
- -
1
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
-3
- -
- -
- -
- -
- Operating Expenses
8
21
27
29
22
43
30
+ Selling, General & Admin
2
3
4
6
6
7
7
+ Research & Development
6
17
23
24
17
37
26
+ Other Operating Expense
- -
- -
- -
-1
-1
-2
-3
Operating Income (Loss)
-8
-20
-24
-29
-22
-43
-30
- Non-Operating (Income) Loss
1
5
-2
1
- -
-1
- -
+ Interest Expense, Net
- -
- -
- -
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
5
-2
1
- -
-1
- -
Pretax Income
-8
-25
-22
-30
-22
-42
-30
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-8
-25
-22
-30
-22
-42
-30
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-8
-25
-22
-30
-22
-42
-30
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-8
-25
-22
-30
-22
-42
-30
- Preferred Dividends
- -
3
1
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-9
-27
-23
-30
-22
-42
-30
EBIT
-8
-20
-24
-29
-22
-43
-30
EBITDA
-8
-20
-24
-29
-22
-42
-30
EBITDA Margin (%)
-346.45
-2,287.91
-864.49
- -
- -
- -
- -
EBITA
-8
-20
-24
-29
-22
-43
-30
Gross Margin (%)
15.07
100
100
- -
- -
- -
- -
Operating Margin (%)
-347.47
-2,295.12
-874.76
- -
- -
- -
- -
Profit Margin (%)
-371.18
-2,866.98
-801.78
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
8
8
3
8
9
12
19
Basic EPS, GAAP
-1.13
-3.48
-7.46
-3.51
-2.44
-3.43
-1.62
Basic EPS from Cont Ops
-1.07
-3.12
-7.02
-3.51
-2.44
-3.43
-1.62
Diluted Weighted Avg Shares
8
8
3
8
9
12
19
Diluted EPS, GAAP
-1.13
-3.48
-7.46
-3.51
-2.44
-3.43
-1.62
Diluted EPS from Cont Ops
-1.07
-3.12
-7.02
-3.51
-2.44
-3.43
-1.62

Balance Sheet (USD)

APIChat
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
Total Current Assets
22
25
28
26
13
24
12
+ Cash, Cash Equivalents & STI
22
25
24
21
8
18
5
+ Cash & Cash Equivalents
22
25
24
21
8
18
5
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
2
- -
- -
- -
1
+ Accounts Receivable, Net
- -
- -
2
- -
- -
- -
1
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
2
5
4
6
6
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
1
3
2
2
2
3
+ Property, Plant & Equip, Net
- -
1
1
1
1
1
2
+ Property, Plant & Equip
- -
1
2
2
2
3
4
- Accumulated Depreciation
- -
- -
- -
1
1
2
2
+ LT Investments & Receivables
- -
- -
1
- -
- -
- -
- -
+ LT Investments
- -
- -
1
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
1
1
1
1
1
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
1
1
1
1
1
Total Assets
23
26
32
28
15
27
15
+ Payables & Accruals
2
3
5
5
3
12
12
+ Accounts Payable
1
1
2
2
2
5
2
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
2
2
2
3
1
6
10
+ ST Debt
- -
- -
- -
- -
- -
1
5
+ ST Borrowings
- -
- -
- -
- -
- -
1
4
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
1
+ Other ST Liabilities
- -
- -
- -
15
19
21
20
+ Deferred Revenue
- -
- -
- -
15
19
21
20
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
- -
Total Current Liabilities
2
3
5
19
22
33
37
+ LT Debt
- -
- -
- -
- -
- -
5
1
+ LT Borrowings
- -
- -
- -
- -
- -
5
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
1
+ Other LT Liabilities
6
12
- -
5
1
1
1
+ Accrued Liabilities
- -
- -
- -
5
1
1
1
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
6
12
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
6
12
- -
5
1
7
2
Total Liabilities
9
15
5
24
24
40
39
+ Preferred Equity and Hybrid Capital
59
74
- -
- -
- -
- -
- -
+ Share Capital & APIC
-25
-15
97
104
114
152
166
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
-25
-15
97
104
114
152
166
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-20
-48
-71
-101
-123
-165
-196
+ Other Equity
- -
- -
- -
- -
- -
- -
5
Equity Before Minority Interest
14
11
26
4
-9
-13
-24
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
Total Equity
14
11
26
4
-9
-13
-24
Total Liabilities & Equity
23
26
32
28
15
27
15
Shares Outstanding
8
8
8
9
10
18
27
Number of Employees
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
2
Net Debt
-22
-25
-24
-21
-8
-12
-1
Net Debt to Equity
-161.82
-219.45
-92.11
-574.72
86.59
92.45
2.38
Tangible Common Equity Ratio
-200.85
-237.6
83.22
12.9
-57.71
-49.05
-165.21
Current Ratio
9.35
7.98
5.35
1.34
0.57
0.73
0.32
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
+ Net Income
-8
-25
-22
-30
-22
-42
-30
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
1
7
- -
3
2
8
2
+ Stock-Based Compensation
1
2
2
2
2
2
1
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
1
5
-2
1
- -
6
- -
+ Chg in Non-Cash Work Cap
1
- -
-3
18
-1
11
-1
+ (Inc) Dec in Accts Receiv
- -
- -
-2
- -
-1
- -
-1
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-2
-1
1
- -
- -
+ Inc (Dec) in Accts Payable
- -
- -
2
- -
-1
8
- -
+ Inc (Dec) in Other
- -
- -
-1
20
- -
2
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-6
-18
-24
-8
-20
-23
-29
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
-1
-1
- -
- -
-1
- -
+ Acq of Fixed Prod Assets
- -
-1
-1
- -
- -
-1
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
25
5
8
30
13
+ Increase in Capital Stock
- -
- -
25
5
8
30
13
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
-1
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
-1
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
-1
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
-1
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
1
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
-1
-2
- -
- -
-1
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
1
5
3
+ Cash From Debt
- -
- -
- -
- -
1
5
5
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
-2
+ Other Financing Activities
26
21
- -
- -
- -
- -
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
26
21
25
5
9
35
15
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
19
3
-1
-3
-12
11
-14
EBITDA
-8
-20
-24
-29
-22
-42
-30
EBITDA Margin (%)
-346.45
-2,287.91
-864.49
- -
- -
- -
- -
Free Cash Flow
-6
-18
-25
-8
-21
-23
-29
Net Cash Paid for Acquisitions
- -
- -
1
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-6
-101
-8
-20
-18
-26
Free Cash Flow per Basic Share
-0.77
-2.31
-7.93
-0.99
-2.27
-1.91
-1.56
Price/Free Cash Flow
- -
- -
-1.48
-4.71
-2.77
-1.28
-0.76
Cash Flow to Net Income
0.72
0.71
1.1
0.27
0.92
0.54
0.96
Capital Expenditures
- -
-1
-1
- -
- -
-1
- -